Drug rebates: Who pays, who profits, how can we make drug prices more equitable?

June 5, 2017 A new study led by Dr. Stacie Dusetzina examines how drug rebates result in disparities in medication costs. She and colleagues show that rebates may increase costs for Medicare Part D beneficiaries and the federal Medicare program, while decreasing costs for drug manufacturers and Part D (drug) insurance plans.

New study investigates perceptions, ethics of treatment interruptions in HIV cure research

June 2, 2017 Two faculty members from the Gillings School investigated how stakeholders respond to the concept of using analytical treatment interruptions to test the efficacy of potential HIV cure research strategies in the absence of antiretroviral therapy.

Drug company payments associated with physicians’ prescribing choices for cancer drugs

June 2, 2017 Gillings School investigators found an association between physicians receiving payments from pharmaceutical companies for meals, talks and travel and those physicians prescribing the companies' drugs for two types of cancer. The findings were presented at the annual meeting of the American Society of Clinical Oncology.

Study evaluates the CDC’s Tips From Former Smokers campaign, finds it an effective smoking cessation program

May 12, 2017 A new study assesses the impact of Tips From Former Smokers (Tips), the first federally funded tobacco education campaign in the U.S., which has been aired annually by the Centers for Disease Control and Prevention (CDC) since 2012. Doctoral student Paul Shafer, also a research economist at RTI International, is co-author of the study, published May 12 in Health Education and Behavior.

Doctoral student co-authors two studies on the difficulties of quitting smoking

April 26, 2017 Paul Shafer, health policy and management doctoral student, co-authored two articles that examine aspects of the behaviors of smokers who are trying to quit or who are exposed to antismoking advertising. The articles appear in Preventing Chronic Disease and the Journal of Health Communication.

Oberlander’s ‘Perspective’ considers reasons for failure of Obamacare repeal

April 6, 2017 Dr. Jonathan Oberlander, in a New England Journal of Medicine 'Perspective' article, discusses why the initial effort to repeal and replace the Affordable Care Act was such a monumental failure.

Veterans’ care for PTSD not hindered by co-occurring substance use disorders

March 20, 2017 A study led by Dr. Alyssa Mansfield (Damon) found that veterans with more than one substance use disorder were not hindered from receiving outpatient specialty post-traumatic stress disorder (PTSD) treatment or sufficient psychotherapy. Findings were published online March 1 in the journal Psychiatric Services.

Study validates a survey tool to assess patient-centered communication in cancer care settings

March 2, 2017 Dr. Bryce Reeve and colleagues at RTI found supporting evidence for the reliability of a survey instrument that assesses patient-centered communication in cancer care settings. Their findings were published Feb. 10 in Patient Education and Counseling.

Gillings School is top public health school at public university for NIH funding

February 16, 2017 The National Institutes of Health (NIH) has announced that the Gillings School was the top public health school at a public university in receiving NIH funding during fiscal year 2016. The School received 107 awards, for a total of $65,454,312 in funding.

NEJM ‘Perspective’ explores use of patient-reported outcomes in improving clinical care

February 2, 2017 Dr. Ethan Basch authored a ‘Perspective’ column published in the Jan. 12 New England Journal of Medicine. The article calls for digitized patient-reported outcomes to be more fully available to physicians as a means of improving patients’ care.

...
8
9
10
1
6
7
11
12
13
...
RELATED PAGES
CONTACT INFORMATION
Visit our communications and marketing team page.
Contact sphcomm@unc.edu with any media inquiries or general questions.

Communications and Marketing Office
125 Rosenau Hall
CB #7400
135 Dauer Drive
Chapel Hill, NC 27599-7400